HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

KCCFHCQVCFTTKGL Tat(29-43) human epitope
  CLHCQVCFI Tat(31-39) A2 human epitope
  CfHCQVCFI Tat(31-39) observed variant
  CFHCQVCFITKGLGISYGRK Tat(31-50) human epitope
  HCQVCFIsKGLGISYGRK Tat(31-50) observed variant
   FHCQVCFMTK Tat(32-41) human epitope
   FHCQVCFMkK Tat(32-41) observed variant
   FHCQVCFMiK Tat(32-41) observed variant
   lHCQVCFMkK Tat(32-41) observed variant
   FHCQVCFiTK Tat(32-41) observed variant
   lHCQVCFMTK Tat(32-41) observed variant
   FnCQVCFMTK Tat(32-41) observed variant
   FHCQdCFMkK Tat(32-41) observed variant
   FHCQVyFMTK Tat(32-41) observed variant
   kHCQVCFMlK Tat(32-41) escape documented in this paper
   FHCQVCFtTK Tat(32-41) escape documented in this paper
   FHCQVCFITK Tat(32-41) human epitope
   FHCQVCFMTK Tat(32-41) human epitope
   FHCQVCFtTK Tat(32-41) escape documented in this paper
   FHCQVCFtTe Tat(32-41) observed variant
   lHCQVCFMkK Tat(32-41) escape documented in this paper
   YHCLVCFQTKGLGISYGR Tat(32-49) C*02 human epitope
   YHCLVCFQTKGLGISYGR Tat(32-49) C*02 human epitope
   FHCQVCFTTKGLGISYGR Tat(32-49) human epitope
    HCQVCFISKGLGISYGRK Tat(33-50) human epitope
    CFHCQVCFItKGLGISYGRK Tat(33-50) observed variant
    HCQVCFISKGLGIpYGRK Tat(33-50) observed variant
    HCQVCFISKGLGIn-GRK Tat(33-50) observed variant
    HCQVCFISKGLGIS-GRK Tat(33-50) observed variant
    HCQVCFITKGLGISYGRK Tat(33-50) human epitope
       VCFTTKGLGI Tat(36-45) B*15 human epitope
       VCFMTKGLGI Tat(36-45) B*15:01 human epitope
       VCFtTKGLGI Tat(36-45) escape documented in this paper
       VCFtTeGLGI Tat(36-45) observed variant
       VCFMkKGLGI Tat(36-45) escape documented in this paper
       VCFITKALGI Tat(36-45) human epitope
       VCFMTKGLGI Tat(36-45) human epitope
       VCFMkKGLGI Tat(36-45) observed variant
       VCFMTKGLGv Tat(36-45) observed variant
       VCFMTKGLsI Tat(36-45) observed variant
       dCFMkKGLGI Tat(36-45) observed variant
       VCFiTKGLGI Tat(36-45) observed variant
       VyFMTKGLGI Tat(36-45) observed variant
       VCFMiKGLGI Tat(36-45) observed variant
       VCFMlKGLGI Tat(36-45) escape documented in this paper
       VCFtTKGLGI Tat(36-45) escape documented in this paper
       VCFQTKGLGISYGRK Tat(36-50) human epitope
       VCFQTKGLGISYGRK Tat(36-50) human epitope
       VCFTTKALGISYGRKKR Tat(36-52) human epitope
         FQTKGLGISY Tat(38-47) A*26 human epitope
         FQTKGLGISY Tat(38-47) A*68:02 human epitope
         FQTKGLGISY Tat(38-47) B15 human epitope
         FQTKGLGISY Tat(38-47) B*15:01 human epitope
         FMTKGLGISY Tat(38-47) B*15:01 human epitope
         FMkKGLGISY Tat(38-47) observed variant
         FMiKGLGISY Tat(38-47) observed variant
         FiTKGLGISY Tat(38-47) observed variant
         FMTKGLGvSY Tat(38-47) observed variant
         FMTKGLGIfY Tat(38-47) observed variant
         FMTKGLsISY Tat(38-47) observed variant
         FMlKGLGISY Tat(38-47) escape documented in this paper; processing
         FtTKGLGISY Tat(38-47) susceptible form
         FQTKGLGISY Tat(38-47) B*15:03 human epitope
         FlnKGLGISY Tat(38-47) observed variant
         FQTKGLGIyY Tat(38-47) inferred escape; observed variant
         FlTKGLGISY Tat(38-47) inferred escape; observed variant
         FQTKGLsISY Tat(38-47) inferred escape; observed variant
         FQrKGLGISY Tat(38-47) inferred escape; observed variant
         FQkKGLGISY Tat(38-47) inferred escape; observed variant
         FQTKGLGISY Tat(38-47) B*15:03 human epitope
         FQTKGLGISY Tat(38-47) B*15:03 human epitope
         FQTKGLGISY Tat(38-47) B*15:03 human epitope
         FQTKGLGISY Tat(38-47) B*15:03 human epitope
         FQTKGLGISY Tat(38-47) B*15:03 human epitope
         FQKKGLGISY Tat(38-47) B*15:03 human epitope
         FQtKGLGISY Tat(38-47) diminished response; escape documented in this paper
         FQTKGLGISY Tat(38-47) B*15:03 human epitope
         FQTKGLGISY Tat(38-47) B*15:03 human epitope
         FQTKGLGISY Tat(38-47) B*15:40 human epitope
         FQTKGLGISY Tat(38-47) C*06 human epitope
         FQTKGLGISY Tat(38-47) C*12 human epitope
         FMKKGLGISY Tat(38-47) human epitope
         FqtKGLGISY Tat(38-47) observed variant
         FQKKGLGISY Tat(38-47) human epitope
          MTKGLGISY Tat(39-47) B*15 human epitope
          MTKGLGISY Tat(39-47) B*15:01 human epitope
          tTKGLGISY Tat(39-47) susceptible form
          tTeGLGISY Tat(39-47) observed variant
          MkKGLGISY Tat(39-47) inferred escape; processing
          MTKALGISY Tat(39-47) C*12:02 human epitope
          TKKGLGISY Tat(39-47) non-susceptible form
          IKKGLGISY Tat(39-47) non-susceptible form
          ITKGLGISY Tat(39-47) human epitope
          ITKGLGISH Tat(39-47) human epitope
          ITKGLGISy Tat(39-47) escape documented in this paper
          ITKGLdISy Tat(39-47) escape documented in this paper
          IkKGLGISy Tat(39-47) escape documented in this paper
          QTKGLGISY Tat(39-47) human epitope
          ITKGLGISY Tat(39-47) human epitope
          ITKGLGISh Tat(39-47) susceptible form
          ITKGLdISY Tat(39-47) escape documented in this paper
          IkKGLGISY Tat(39-47) escape documented in this paper
          ITKALGISY Tat(39-47) human epitope
          ITKGLGISYGR Tat(39-49) A*01 human epitope
          ITKGLGISYGR Tat(39-49) A*11 human epitope
          ITKGLGISYGR Tat(39-49) A*25 human epitope
          ITKGLGISYGR Tat(39-49) A*31 human epitope
          ITKGLGISYGR Tat(39-49) A*68 human epitope
          ITKGLGISYGR Tat(39-49) A68 human epitope
          ITKGLGISYGR Tat(39-49) A68 human epitope
          ITKGLGISYGR Tat(39-49) A*68:01 human epitope
          ITKGLGISYGR Tat(39-49) A*68:01 human epitope
          ITKGLGISYGR Tat(39-49) A*68:01 human epitope
          ITKGLGISYGR Tat(39-49) A*68:01 human epitope
          tTKGLGISYGR Tat(39-49) observed variant
          ITKGsGISYGR Tat(39-49) observed variant
          ITKGLGISYGR Tat(39-49) A*68:01 human epitope
          ITKGLGISYGR Tat(39-49) B*07 human epitope
          ITKGLGISYGR Tat(39-49) B*15:01 human epitope
          ITKGLGISYGR Tat(39-49) B*15:03 human epitope
          ITKGLGISYGR Tat(39-49) B*35:02, B*35:03, B*53:01 human epitope
          ITKGLGISYGR Tat(39-49) B*49 human epitope
          ITKGLGISYGR Tat(39-49) B*81 human epitope
          ITKGLGISYGR Tat(39-49) C*12 human epitope
          ITKGLGISYGR Tat(39-49) C*14 human epitope
          MKKGLGISYGR Tat(39-49) human epitope
          itKGLGISYGR Tat(39-49) observed variant
           TKGLGISY Tat(40-47) B*15:03 human epitope
           TKALGISYGR Tat(40-49) human epitope
            KGLGISYGRKKRRQRRRA Tat(41-58) human epitope
               GISYGRKKRRQRRRAHQN Tat(44-61) human epitope
                    RKKRRQRRR Tat(49-57) H-2d mouse epitope
                    RKKRRQRRR Tat(49-57) mouse epitope
                    RKKRRQRRR Tat(49-57) mouse epitope
                    RKKRRQRRRAPQDSQTHQ Tat(49-66) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health